Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MBL
Japanmblbio.com ↗
- Ownership
- Private
- Employees
- ~400
- Development stage
- Other
01
Overview
MBL is a leading Japanese company commercializing in vitro diagnostics and research reagents—primarily focusing on autoimmune, cancer, gynecological, and infectious diseases—offering antibody-based diagnostics, companion diagnostics, and immune monitoring reagents used worldwide.
- Therapeutic areas
- ImmunologyInfectious DiseasesOncologyNeurologyWomen's Health
- Modalities
- AntibodyRecombinant proteinMonoclonal antibodyFluorescent proteinELISA kitMHC multimer
- Industry
- Molecular Diagnostics
02
Partnerships
JSR Life Sciences companiesImmunoPrecise Antibodies (IPA)Agappe (technology transfer partnership)
Beyond the preview
Go deeper on MBL.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MBL.